United States · FDA National Drug Code directory
Sertraline Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-013_50d67885-52a9-49a4-9f2a-f82749747222
- Product NDC
- 65862-013
- Form
- TABLET, FILM COATED
- Composition / generic term
- Sertraline Hydrochloride
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070206
- Source listing expiry
- 20261231
Source-listed ingredients
- SERTRALINE HYDROCHLORIDE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (65862-013-01) · 65862-013-01
- 500 TABLET, FILM COATED in 1 BOTTLE (65862-013-05) · 65862-013-05
- 2500 TABLET, FILM COATED in 1 BOTTLE (65862-013-25) · 65862-013-25
- 30 TABLET, FILM COATED in 1 BOTTLE (65862-013-30) · 65862-013-30
- 50 TABLET, FILM COATED in 1 BOTTLE (65862-013-50) · 65862-013-50
- 60 TABLET, FILM COATED in 1 BOTTLE (65862-013-60) · 65862-013-60
- 90 TABLET, FILM COATED in 1 BOTTLE (65862-013-90) · 65862-013-90
- 1000 TABLET, FILM COATED in 1 BOTTLE (65862-013-99) · 65862-013-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →